• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

独立和联合的身体活动和充足的工作日睡眠时间与代谢功能障碍相关的脂肪性肝病的关系。

Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease.

机构信息

Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.

Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

Clin Res Hepatol Gastroenterol. 2024 Apr;48(4):102320. doi: 10.1016/j.clinre.2024.102320. Epub 2024 Mar 12.

DOI:10.1016/j.clinre.2024.102320
PMID:38484840
Abstract

BACKGROUND

The independent and joint association of physical activity (PA) and weekday sleep duration with metabolic dysfunction-associated steatotic liver disease (MASLD) remain unclear.

AIMS

We intended to explore this association in the United States.

METHODS

This cross-sectional study recruited 4974 individuals from the National Health and Nutrition Examination Survey between 2017 and 2018. Information regarding PA and weekday sleep duration was obtained through questionnaires. Metabolic associated fatty liver disease (MAFLD) was diagnosed by transient elastography based on the consensus definitions. Multivariable logistic regression models were employed to investigate the independent and joint association of PA and weekday sleep duration with MAFLD.

RESULTS

Of the 4974 subjects, engaging in active PA or sustaining adequate sleep duration was associated with decreased the odds of MAFLD (p < 0.05). Specifically, active leisure-time PA was linked to lower 37 % odds of MAFLD (OR, 0.63; 95 % CI, 0.55-0.73). Individuals who had one to twice times (150-299 min/week) or more than twice (≥300 min/week) the recommended amount of leisure-time PA by PA Guidelines had 19 % (OR, 0.81; 95 % CI, 0.67-0.99) and 45 % (OR, 0.55; 95 % CI, 0.47-0.65) lower odds of MAFLD, respectively (P for trend <0.001). Individuals with adequate weekday sleep duration was associated with 24 % lower odds of MAFLD (OR, 0.76;95 % CI,0.67-0.88). Notably, active PA combined with adequate weekday sleep duration significantly decreased the odds ratios for MAFLD by 35 % (OR: 0.65, 95 % CI, 0.52-0.80). However, in individuals with significant alcohol use, the joint effect of total PA and weekday sleep duration on MAFLD was not statistically significant.

CONCLUSIONS

Both active PA and adequate weekday sleep duration were inversely associated with the risk of MASLD independently, while combining them could further lower the risk of MASLD.

摘要

背景

体力活动(PA)和工作日睡眠时长与代谢相关脂肪性肝病(MASLD)的独立和联合关联仍不清楚。

目的

我们旨在探讨这种关联在美国人群中的情况。

方法

本横断面研究于 2017 年至 2018 年期间招募了来自全国健康和营养检查调查(NHANES)的 4974 名个体。通过问卷调查获取关于 PA 和工作日睡眠时长的信息。使用瞬时弹性成像技术基于共识定义诊断代谢相关脂肪性肝疾病(MAFLD)。采用多变量逻辑回归模型探讨 PA 和工作日睡眠时长与 MAFLD 的独立和联合关联。

结果

在 4974 名受试者中,进行积极的 PA 或保持足够的睡眠时长与 MAFLD 的几率降低有关(p<0.05)。具体而言,积极的休闲时间 PA 与 MAFLD 的几率降低 37%相关(OR,0.63;95%CI,0.55-0.73)。根据 PA 指南,每周进行一次到两次(150-299 分钟/周)或两次以上(≥300 分钟/周)推荐量的休闲时间 PA 的个体 MAFLD 的几率分别降低 19%(OR,0.81;95%CI,0.67-0.99)和 45%(OR,0.55;95%CI,0.47-0.65)(P 趋势<0.001)。工作日睡眠充足的个体 MAFLD 的几率降低 24%(OR,0.76;95%CI,0.67-0.88)。值得注意的是,积极的 PA 结合充足的工作日睡眠时长可使 MAFLD 的比值比降低 35%(OR:0.65,95%CI,0.52-0.80)。然而,在大量饮酒的个体中,PA 总量和工作日睡眠时长对 MAFLD 的联合作用无统计学意义。

结论

积极的 PA 和足够的工作日睡眠时长均与 MASLD 的风险呈负相关,独立相关,而两者结合可进一步降低 MASLD 的风险。

相似文献

1
Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease.独立和联合的身体活动和充足的工作日睡眠时间与代谢功能障碍相关的脂肪性肝病的关系。
Clin Res Hepatol Gastroenterol. 2024 Apr;48(4):102320. doi: 10.1016/j.clinre.2024.102320. Epub 2024 Mar 12.
2
Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017-2020.2017-2020 年 NHANES 中成年人身体活动与 MAFLD/MASLD 和 LF 的关系。
Wien Klin Wochenschr. 2024 May;136(9-10):258-266. doi: 10.1007/s00508-023-02314-0. Epub 2024 Jan 3.
3
Sleep factors were associated with a higher risk of MAFLD and significant fibrosis.睡眠因素与 MAFLD 和显著纤维化的风险增加相关。
Sleep Breath. 2024 Jun;28(3):1381-1391. doi: 10.1007/s11325-024-03017-0. Epub 2024 Mar 22.
4
Joint association of sleep quality and physical activity with metabolic dysfunction-associated fatty liver disease: a population-based cross-sectional study in Western China.睡眠质量和身体活动与代谢功能障碍相关脂肪性肝病的联合关联:中国西部一项基于人群的横断面研究。
Nutr Diabetes. 2024 Jul 22;14(1):54. doi: 10.1038/s41387-024-00312-3.
5
Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.美国成年人中NAFLD、MAFLD和MASLD的特征及死亡率结果比较。
Liver Int. 2024 Apr;44(4):1051-1060. doi: 10.1111/liv.15856. Epub 2024 Jan 31.
6
Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.慢性肾脏病发生时代谢功能障碍相关脂肪/脂肪变性肝病的严重程度和缓解情况。
J Am Heart Assoc. 2024 Mar 5;13(5):e032604. doi: 10.1161/JAHA.123.032604. Epub 2024 Feb 23.
7
Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.代谢相关脂肪性肝病命名对脂肪性肝病患病率和筛查的影响:亚洲前瞻性人群调查。
J Gastroenterol Hepatol. 2024 Aug;39(8):1636-1647. doi: 10.1111/jgh.16554. Epub 2024 May 2.
8
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.MAFLD 标准比 MASLD 标准更能预测慢性肾脏病的风险。
Ann Hepatol. 2024 Sep-Oct;29(5):101512. doi: 10.1016/j.aohep.2024.101512. Epub 2024 May 6.
9
Identifying the most critical behavioral lifestyles associated with MAFLD: evidence from the NHANES 2017-2020.识别与 MAFLD 最相关的关键行为生活方式:来自 NHANES 2017-2020 的证据。
Front Endocrinol (Lausanne). 2024 Jul 25;15:1375374. doi: 10.3389/fendo.2024.1375374. eCollection 2024.
10
Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study.脂肪性肝病亚型、肌肉减少症和肝纤维化对全因死亡率和特定病因死亡率的影响:一项15.7年的队列研究。
BMC Gastroenterol. 2025 Feb 11;25(1):75. doi: 10.1186/s12876-025-03661-0.

引用本文的文献

1
Association of cardiovascular health metrics and metabolic associated fatty liver disease: Methodological limitations, and future directions.心血管健康指标与代谢相关脂肪性肝病的关联:方法学局限性及未来方向。
World J Hepatol. 2025 Mar 27;17(3):105635. doi: 10.4254/wjh.v17.i3.105635.
2
[Different Types of Obesity Play a Modifying Role in the Association Between Physical Activity and Metabolic Dysfunction-Associated Fatty Liver Disease].[不同类型的肥胖在体力活动与代谢功能障碍相关脂肪性肝病的关联中起调节作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Jan 20;56(1):149-155. doi: 10.12182/20250160108.
3
Association of Life's Essential 8 and Life's Simple 7 with metabolic-associated fatty liver disease in the United States.
美国生命基本八项和生命简单七项与代谢相关脂肪性肝病的关联
World J Hepatol. 2025 Feb 27;17(2):97741. doi: 10.4254/wjh.v17.i2.97741.
4
Life's essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease.美国患有代谢功能障碍相关脂肪性肝病的成年人的生命必需8要素与死亡率
BMC Public Health. 2024 Dec 18;24(1):3411. doi: 10.1186/s12889-024-20919-6.
5
Diagnostic indicators and lifestyle interventions of metabolic-associated fatty liver disease.代谢相关脂肪性肝病的诊断指标及生活方式干预
Front Nutr. 2024 Jun 14;11:1424246. doi: 10.3389/fnut.2024.1424246. eCollection 2024.